London, England -- (SBWIRE) -- 03/15/2012 -- Brazil is the most populated country in Latin America, and in 2010, with a population of 193 million, was the fifth most populated country in the world. It currently has a demographic advantage in terms of a large working age population. The available data for the age-wise distribution of the Brazilian population shows that the population in the working age group of 20-59 years increased from 2005 to 2010. The elderly population (60 years and above) is expected to increase in the future to account for more than 13% of the population by 2020. The disease burden associated with a large elderly population will require significant healthcare expenditure, thereby acting as a positive driver for the Brazilian healthcare market.

The pharmaceutical market in Brazil was estimated at $19 billion in 2010, having increased from $9 billion in 2005 at a Compound Annual Growth Rate (CAGR) of 21%. It is expected to reach $55 billion by 2020. Brazil is one of the fastest growing pharmaceutical markets in the world. Approximately 24% of the market comprises generic drugs. Government regulations and initiatives have supported the domestic pharmaceutical industry’s generic development, and growth is expected to remain high due to the expiry of several blockbuster drugs in the near future and government’s emphasis on increasing the use of generics.

The medical device market in Brazil was estimated at $7 billion in 2010. It ranks among the top 10 markets in the world and is the largest in South America. It is projected to reach $14 billion by 2020 at a CAGR of 6.8% from 2011.

In 2010, the main segments of the medical devices market were ophthalmic devices ($1.4 billion), in vitro diagnostics devices ($810m) and diagnostic imaging devices ($697m).

For Sample Pages, please click or add the below link to your browser:
http://www.globaldata.com/reportstore/RequestSamplePages.aspx?ID=Healthcare-Regulatory-and-Reimbursement-Landscape-Brazil&Title=Pharmaceuticals_and_Healthc&ReportType=Industry_Report&companyID=sdwire

The medical device market in Brazil is expected to grow significantly in the future due to the increasingly elderly population, insurance coverage, advances in medical technology, and increasing awareness of and emphasis on early diagnosis. The key segments expected to show high growth in the future include cardiology, ophthalmology, rehabilitation, and plastic surgery.

Approximately 50% of demand for medical equipment in Brazil is met through imports. The largest share of the import market is held by the US, although European and Japanese suppliers are also considered to have a good reputation. A significant reduction in trade barriers such as tariffs and import licensing has resulted in high growth in the medical equipment sector.

Brazil’s hospital system comprises a significant part of both the public and private sector. For activities classified under the Unified Health System (Sistema Único de Saúde, SUS) plan, private hospital expenses are paid by public funds. In 2010, approximately 67% of hospitals were publicly owned. The share of private hospitals increased steadily from 30% in 2005 to 33% in 2010.

GlobalData, the industry analysis specialist, has released its new report, “Healthcare, Regulatory and Reimbursement Landscape - Brazil”. The report is an essential source of information and analysis on Brazil’s healthcare, regulatory and reimbursement landscape, and identifies the key trends in the healthcare market. The report also provides insights into the country’s demographic, regulatory, and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. The report is built using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalData’s team of industry experts.

For further details, please click or add the below link to your browser:
http://www.globaldata.com/reportstore/Report.aspx?ID=Healthcare-Regulatory-and-Reimbursement-Landscape-Brazil&ReportType=Industry_Report&coreindustry=Industry_Report&Title=Pharmaceuticals_and_Healthc&companyID=sdwire

Visit our report store: http://www.globaldata.com/reportstore

For more details contact:
pressreleases@globaldata.com

North America:
+1 646 395 5477

Europe:
+44 207 753 4299
+44 1204 543 533

Asia Pacific:
+91 40 6616 6782